| scholarly article | Q13442814 |
| P50 | author | Jesus Gil | Q55472013 |
| P2093 | author name string | Nikolay Popov | |
| P2860 | cites work | Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression | Q21092443 |
| INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis | Q21562488 | ||
| Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus | Q24298715 | ||
| The Polycomb group protein EZH2 directly controls DNA methylation | Q24299020 | ||
| Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets | Q24301123 | ||
| Role of histone H2A ubiquitination in Polycomb silencing | Q24305090 | ||
| Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls | Q24550675 | ||
| Rnf2 (Ring1b) deficiency causes gastrulation arrest and cell cycle inhibition | Q24554110 | ||
| Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a | Q24633736 | ||
| A common allele on chromosome 9 associated with coronary heart disease | Q24647989 | ||
| Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression | Q24654249 | ||
| Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA | Q24655224 | ||
| Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS | Q24657459 | ||
| The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells | Q24680814 | ||
| CDK inhibitors: positive and negative regulators of G1-phase progression | Q27860983 | ||
| A common variant of the p16(INK4a) genetic region is associated with physical function in older people | Q36136695 | ||
| Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. | Q36572080 | ||
| SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus | Q36710858 | ||
| Gene silencing by DNA methylation in haematological malignancies | Q36816162 | ||
| Members of a family of JmjC domain-containing oncoproteins immortalize embryonic fibroblasts via a JmjC domain-dependent process | Q36882963 | ||
| Cancer and ageing: convergent and divergent mechanisms | Q36918634 | ||
| Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation | Q37426642 | ||
| Polycomb group proteins: navigators of lineage pathways led astray in cancer | Q37620148 | ||
| Signatures of mutation and selection in the cancer genome | Q39737975 | ||
| Transcription factor YY1 functions as a PcG protein in vivo | Q39738160 | ||
| p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a | Q40090783 | ||
| P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells | Q40618783 | ||
| A region of the human HOXD cluster that confers polycomb-group responsiveness | Q42067778 | ||
| A Polycomb group protein complex with sequence-specific DNA-binding and selective methyl-lysine-binding activities | Q42424377 | ||
| The Drosophila Polycomb group gene pleiohomeotic encodes a DNA binding protein with homology to the transcription factor YY1. | Q47071388 | ||
| Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. | Q52526599 | ||
| Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies | Q63641308 | ||
| Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues | Q73017608 | ||
| An INKlination for epigenetic control of senescence | Q79790429 | ||
| Role of histone H3 lysine 27 methylation in Polycomb-group silencing | Q28131795 | ||
| Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals | Q28131802 | ||
| Polycomb CBX7 has a unifying role in cellular lifespan | Q28188425 | ||
| Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence | Q28203134 | ||
| The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence | Q28245403 | ||
| Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers | Q28251857 | ||
| A cell cycle regulator potentially involved in genesis of many tumor types | Q28251933 | ||
| Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest | Q28270478 | ||
| MAPKAP kinase 3pK phosphorylates and regulates chromatin association of the polycomb group protein Bmi1 | Q28295095 | ||
| The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15(Ink4b) | Q28296070 | ||
| Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene | Q28505536 | ||
| Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice | Q28511962 | ||
| Ink4a/Arf expression is a biomarker of aging | Q28570483 | ||
| Mouse polycomb proteins bind differentially to methylated histone H3 and RNA and are enriched in facultative heterochromatin | Q28587001 | ||
| Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes | Q28680760 | ||
| A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants | Q29547210 | ||
| Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels | Q29547214 | ||
| The landscape of somatic copy-number alteration across human cancers | Q29547648 | ||
| A common variant on chromosome 9p21 affects the risk of myocardial infarction | Q29614954 | ||
| Histone methyltransferase activity of a Drosophila Polycomb group repressor complex | Q29615394 | ||
| Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites | Q29615395 | ||
| The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus | Q29619815 | ||
| Nucleolar Arf sequesters Mdm2 and activates p53 | Q29620244 | ||
| Epigenetic stem cell signature in cancer | Q29622897 | ||
| Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer | Q29622925 | ||
| A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing | Q33268624 | ||
| Linkage and association study of late-onset Alzheimer disease families linked to 9p21.3. | Q33652208 | ||
| Pc-G/trx-G and the SWI/SNF connection: developmental gene regulation through chromatin remodeling | Q33855686 | ||
| Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2. | Q33914791 | ||
| Tissue-specific p19Arf regulation dictates the response to oncogenic K-ras | Q33933332 | ||
| Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice | Q34121996 | ||
| Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice | Q34549869 | ||
| The regulation of INK4/ARF in cancer and aging | Q34575801 | ||
| Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. | Q34619960 | ||
| JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes | Q34712349 | ||
| Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus | Q34940029 | ||
| Frequent p16-independent inactivation of p14ARF in human melanoma | Q35541602 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 685-690 | |
| P577 | publication date | 2010-11-01 | |
| P1433 | published in | Epigenetics | Q15753739 |
| P1476 | title | Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health | |
| P478 | volume | 5 |
| Q48146300 | A genetic variant in CDKN2A/B gene is associated with the increased risk of breast cancer. |
| Q90459402 | ANRIL rs1333049 C/G polymorphism and coronary artery disease in a North Indian population - Gender and age specific associations |
| Q28394102 | ANRIL: molecular mechanisms and implications in human health |
| Q39479395 | Aberrant Endometrial DNA Methylome and Associated Gene Expression in Women with Endometriosis |
| Q61801116 | Aberrant Expression of p14 in Human Cancers: A New Biomarker? |
| Q90508367 | Activity of PRC1 and Histone H2AK119 Monoubiquitination: Revising Popular Misconceptions |
| Q52327301 | Analysis of the 9p21.3 sequence associated with coronary artery disease reveals a tendency for duplication in a CAD patient. |
| Q98613710 | Association between Coronary Artery Disease and rs10757278 and rs1333049 Polymorphisms in 9p21 Locus in Iran |
| Q37623109 | Association of CDKN2B-AS1 rs1333049 with Brain Diseases: A Case-control Study and a Meta-analysis |
| Q28596636 | Association of new deletion/duplication region at chromosome 1p21 with intellectual disability, severe speech deficit and autism spectrum disorder-like behavior: an all-in approach to solving the DPYD enigma |
| Q61799033 | Blood-based analysis of type-2 diabetes mellitus susceptibility genes identifies specific transcript variants with deregulated expression and association with disease risk |
| Q37466544 | CDKN2B methylation is associated with carotid artery calcification in ischemic stroke patients |
| Q37151715 | Chromatin-modifying agents for epigenetic reprogramming and endogenous neural stem cell-mediated repair in stroke |
| Q58786576 | Circ-ZEB1.33 promotes the proliferation of human HCC by sponging miR-200a-3p and upregulating CDK6 |
| Q38953203 | Cisplatin and paclitaxel target significant long noncoding RNAs in laryngeal squamous cell carcinoma |
| Q28252088 | Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders |
| Q38152226 | Clinical significance of the interaction between non-coding RNAs and the epigenetics machinery: challenges and opportunities in oncology |
| Q39091885 | Co-regulation of senescence-associated genes by oncogenic homeobox proteins and polycomb repressive complexes |
| Q36403891 | Copy number variation in patients with cervical artery dissection |
| Q36039537 | DNA methyltransferase 3A promotes cell proliferation by silencing CDK inhibitor p18INK4C in gastric carcinogenesis |
| Q90322513 | Decreased expression of microRNAs targeting type-2 diabetes susceptibility genes in peripheral blood of patients and predisposed individuals |
| Q41613429 | Decreased expression of the long non-coding RNA MLLT4 antisense RNA 1 is a potential biomarker and an indicator of a poor prognosis for gastric cancer |
| Q52578938 | Distinct and Modular Organization of Protein Interacting Sites in Long Non-coding RNAs. |
| Q34645436 | Dysregulation of RNA polymerase I transcription during disease. |
| Q38156169 | EBV finds a polycomb-mediated, epigenetic solution to the problem of oncogenic stress responses triggered by infection |
| Q37989144 | Emerging Roles for Long Non-Coding RNAs in Cancer and Neurological Disorders |
| Q27002577 | Emerging epigenetic mechanisms of long non-coding RNAs |
| Q47869590 | Epigenetic mechanisms underlying nervous system diseases. |
| Q35340073 | Epigenetic mechanisms underlying the pathogenesis of neurogenetic diseases |
| Q38834035 | Epigenetic up-regulation of ribosome biogenesis and more aggressive phenotype triggered by the lack of the histone demethylase JHDM1B in mammary epithelial cells |
| Q26772028 | Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug Response |
| Q34443684 | Expression and significance of histone H3K27 demethylases in renal cell carcinoma |
| Q35748770 | Ezh2 maintains retinal progenitor proliferation, transcriptional integrity, and the timing of late differentiation |
| Q47819316 | Gene regulation of mammalian long non-coding RNA. |
| Q90204402 | Genetic variants of chromosome 9p21.3 region associated with coronary artery disease and premature coronary artery disease in an Asian Indian population |
| Q38603654 | HCV infection, IFN response and the coding and non-coding host cell genome |
| Q89497317 | HMGA2 Antisense Long Non-coding RNAs as New Players in the Regulation of HMGA2 Expression and Pancreatic Cancer Promotion |
| Q92782336 | High Positive Correlations between ANRIL and p16-CDKN2A/p15-CDKN2B/p14-ARF Gene Cluster Overexpression in Multi-Tumor Types Suggest Deregulated Activation of an ANRIL-ARF Bidirectional Promoter |
| Q42700772 | Human papillomavirus dysregulates the cellular apparatus controlling the methylation status of H3K27 in different human cancers to consistently alter gene expression regardless of tissue of origin |
| Q26750099 | Hypoxia-Inducible Histone Lysine Demethylases: Impact on the Aging Process and Age-Related Diseases |
| Q34998257 | Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9 |
| Q41681138 | Inactivation of p15INK4b in chronic arsenic poisoning cases |
| Q31111648 | Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines |
| Q24322448 | Interplay between Homeobox proteins and Polycomb repressive complexes in p16INK⁴a regulation |
| Q47094209 | Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer |
| Q30251397 | Islet biology, the CDKN2A/B locus and type 2 diabetes risk |
| Q37001515 | Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer |
| Q89035951 | LncRNA ANRIL Expression and ANRIL Gene Polymorphisms Contribute to the Risk of Ischemic Stroke in the Chinese Han Population |
| Q92376700 | LncRNAs Regulatory Networks in Cellular Senescence |
| Q26798251 | Long Non-coding RNA ANRIL and Polycomb in Human Cancers and Cardiovascular Disease |
| Q40452568 | Long Noncoding RNA Expression Signatures of Metastatic Nasopharyngeal Carcinoma and Their Prognostic Value. |
| Q38027980 | Long non-coding RNAs and human disease |
| Q37137692 | Long non-coding RNAs and their implications in cancer epigenetics. |
| Q33582854 | Long non-coding RNAs as novel biomarkers and therapeutic targets in head and neck cancers |
| Q37139037 | Long non-coding RNAs in haematological malignancies. |
| Q52628703 | Long non-coding RNAs in melanoma. |
| Q28070169 | Long non-coding RNAs in normal and malignant hematopoiesis |
| Q38063049 | Long noncoding RNA involvement in cancer |
| Q37914513 | Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression |
| Q35747814 | Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets |
| Q34545274 | Mimicking p14ARF phosphorylation influences its ability to restrain cell proliferation |
| Q38195600 | Molecular mechanisms of long ncRNAs in neurological disorders |
| Q21261481 | Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions |
| Q38189361 | Non-coding RNAs as epigenetic regulator of glioma stem-like cell differentiation |
| Q38586823 | Non-coding RNAs deregulation in oral squamous cell carcinoma: advances and challenges |
| Q47751756 | Non-coding RNAs: key regulators of smooth muscle cell fate in vascular disease |
| Q47880484 | Noncoding RNAs in neurodegeneration |
| Q26752617 | Novel Insights into the Role of Long Noncoding RNA in Ocular Diseases |
| Q64092997 | P-TEFb Regulates Transcriptional Activation in Non-coding RNA Genes |
| Q39454286 | Parallel pathways in RAF-induced senescence and conditions for its reversion. |
| Q91586293 | Polycomb Repressive Complex 1 Controls Maintenance of Fungiform Papillae by Repressing Sonic Hedgehog Expression |
| Q35072444 | Polycomb protein SCML2 regulates the cell cycle by binding and modulating CDK/CYCLIN/p21 complexes. |
| Q36975748 | Polycomb repressive complex PRC2 regulates Xenopus retina development downstream of Wnt/β-catenin signaling |
| Q46006380 | Polymorphism in ANRIL is associated with relapse in patients with multiple myeloma after autologous stem cell transplant. |
| Q28071712 | Precise long non-coding RNA modulation in visual maintenance and impairment |
| Q54230653 | Prognostic significance of the expression levels of the p16, p15, and p14 genes in dogs with high-grade lymphoma. |
| Q37699714 | Regulation of CDKN2B expression by interaction of Arnt with Miz-1--a basis for functional integration between the HIF and Myc gene regulatory pathways |
| Q37158599 | Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts |
| Q36439912 | Regulators of gene expression as biomarkers for prostate cancer |
| Q38199695 | Role of Ink4a/Arf locus in beta cell mass expansion under physiological and pathological conditions |
| Q47099122 | Roles of miRNAs and long noncoding RNAs in the progression of diabetic retinopathy |
| Q38734099 | SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development |
| Q38081391 | Senescence in pancreatic carcinogenesis: from signalling to chromatin remodelling and epigenetics |
| Q54251658 | The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency. |
| Q52913525 | The Prognostic Significance of Histone Lysine Demethylase JMJD3/KDM6B in Colorectal Cancer. |
| Q34995156 | The functional role of long non-coding RNA in human carcinomas |
| Q38256144 | The functional role of long non-coding RNAs and epigenetics |
| Q28649974 | The genome landscape of the african green monkey kidney-derived vero cell line |
| Q41020319 | The lncRNA MIR31HG regulates p16(INK4A) expression to modulate senescence |
| Q38045210 | The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine |
| Q97072562 | The role of Long Non-Coding RNAs (lncRNAs) and downstream signaling pathways in Leukemia progression |
| Q57790111 | The silencing of long non-coding RNA ANRIL suppresses invasion, and promotes apoptosis of retinoblastoma cells through ATM-E2F1 signaling pathway |
| Q49961986 | Therapeutic Targeting of Long Non-Coding RNAs in Cancer. |
| Q34036033 | Transcriptional regulation and its misregulation in disease. |
| Q55056740 | Truncated Isoforms of lncRNA ANRIL Are Overexpressed in Bladder Cancer, But Do Not Contribute to Repression of INK4 Tumor Suppressors. |
| Q36292997 | Tumor suppressor ASXL1 is essential for the activation of INK4B expression in response to oncogene activity and anti-proliferative signals |
| Q37218329 | Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines |
| Q53213707 | UVA-induced epigenetic regulation of P16(INK4a) in human epidermal keratinocytes and skin tumor derived cells. |
| Q92294381 | p16INK4A-expressing mesenchymal stromal cells restore the senescence-clearance-regeneration sequence that is impaired in chronic muscle inflammation |
Search more.